Literature DB >> 1587837

Purification and characterization of the vacuolating toxin from Helicobacter pylori.

T L Cover1, M J Blaser.   

Abstract

A vacuolating toxin was purified to homogeneity from broth culture supernatant of the human gastric bacterium, Helicobacter pylori. The procedure for isolating the toxin included ammonium sulfate precipitation, hydrophobic interactive chromatography, size exclusion chromatography, and anion exchange chromatography, which together resulted in a greater than 5000-fold purification of toxin activity. The molecular mass of the purified, denatured toxin was 87,000 +/- 320 daltons, and the native toxin was an aggregate with a molecular mass greater than or equal to 972,000 daltons. The amino-terminal sequence of the purified toxin was partially homologous with internal sequences of numerous transport or ion channel proteins. Antiserum raised against the M(r) = 87,000 protein neutralized toxin activity, whereas preimmune serum did not. When reacted with specific antiserum to the M(r) = 87,000 protein in an enzyme-linked immunosorbent (ELISA) assay, culture supernatants from eight tox+ H. pylori strains produced significantly higher optical density readings than eight tox- supernatants (0.614 +/- 0.11 versus 0.046 +/- 0.01, p less than 0.0001). Sera from H. pylori-infected humans recognized the purified M(r) = 87,000 protein significantly better by ELISA than sera from uninfected persons (0.424 +/- 0.06 versus 0.182 +/- 0.02, p = 0.0009). Finally, ELISA recognition of the purified M(r) = 87,000 protein by human sera was significantly associated with toxin-neutralizing activity (p = 0.019, r = 0.518).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1587837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  238 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin.

Authors:  V Q Nguyen; R M Caprioli; T L Cover
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

3.  Helicobacter pylori vacA genotypes and cagA status and their relationship to associated diseases.

Authors:  Peng Hou; Zhen-Xing Tu; Guo-Ming Xu; Yan-Fang Gong; Xu-Hui Ji; Zhao-Shen Li
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 4.  VacA pores as portable portals for urea.

Authors:  J L Merchant
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

5.  Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

Authors:  M Donati; S Moreno; E Storni; A Tucci; L Poli; C Mazzoni; O Varoli; V Sambri; A Farencena; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

6.  Modification of a mammalian cell protein in the presence of [32P-adenylate]NAD: evidence for ADP ribosylation activity associated with Helicobacter pylori.

Authors:  Carlos W Nossa; Steven R Blanke
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  A novel method for genotyping the Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens.

Authors:  Rui M Ferreira; Jose C Machado; Darren Letley; John C Atherton; Maria L Pardo; Carlos A Gonzalez; Fatima Carneiro; Ceu Figueiredo
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

9.  Relationship between gastric disease and deletion of cag pathogenicity island genes of Helicobacter pylori in gastric juice.

Authors:  Osamu Kawamura; Masami Murakami; Osamu Araki; Takuro Yamada; Sayaka Tomizawa; Yasuyuki Shimoyama; Keiko Minashi; Masaki Maeda; Motoyasu Kusano; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

10.  Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin.

Authors:  E Papini; B Satin; N Norais; M de Bernard; J L Telford; R Rappuoli; C Montecucco
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.